Real-time enrollment status for this focal segmental glomerulosclerosis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:47 AM UTC
| NCT Number | NCT05650619 |
| Recruiting Status | Recruiting |
| Condition | Focal Segmental Glomerulosclerosis |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Michigan |
| Last Updated on CT.gov | April 29, 2026 (Apr 29, 2026) |
As of July 17, 2026: Clinical trial NCT05650619 is currently recruiting participants. This clinical trial study for focal segmental glomerulosclerosis is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Michigan. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05650619 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05650619 was last updated Apr 29, 2026 (April 29, 2026). HelloStudys verifies this status automatically.